Warfarin
Sold as Warfarin austell, Cipla-warfarin, Zywar, Warfarin apex, Warfarin camox, Warfarin biotech, Heamawarin, Cowarin, Aspen warfarin, Coumadin
4-Hydroxy-3-(3-oxo-1-phenylbutyl)chromen-2-one
Drag to rotate. Structure from PubChem CID 54678486.
Background
Registration
- Applicants
- 8
- Registrations
- 21
- Schedule source
- Consolidated Schedules 06 July 2026
Applicants and registrations
| Applicant | Brands | Dosages | Registrations | Schedule | Leaflets |
|---|---|---|---|---|---|
| Austell Pharmaceuticals (Pty) Ltd | Warfarin austell, Warfarin apex, Warfarin camox | 1 mg, 3 mg, 5 mg | 401054, 491055, 491056, 491057, 491058, 491059, 491060, 491061, 491062 | S4 | None |
| Cipla Medpro (Pty) Ltd2 of 3 cancelled | Cipla-warfarin | 1 mg, 3 mg, 5 mg | 410120, 410121, A380422 | S4 | None |
| Zydus Healthcare (Pty) LtdCancelled | Zywar | 1, 2,5, 5 | 410282, 410283, 410284 | S4 | None |
| Biotech Laboratories (Pty) Ltd | Warfarin biotech, Heamawarin | 5 mg | 560658, 560659.658 | S4 | PIPIL |
| Macleods Pharmaceuticals SA (Pty) Ltd | Cowarin | 5 mg | 570426 | S4 | None |
| Pharmacare limited û woodmead | Aspen warfarin | 5 mg | H0742 | S4 | None |
| Boots Pharmaceuticals (Pty) Ltd | Coumadin | 5 | H0753 | S4 | None |
| The Boots Company (SA) (Pty) LtdCancelled | Coumadin | Not stated | H0757 | S4 | None |
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Warfarin 1 MG austell EACH TABLET CONTAINS: WARFARIN SODIUM 1,0 mg | 1 mg | 40105449/8.2/1054 | Registered | S4 | None |
| Cipla-warfarin 1 MG EACH TABLET CONTAINS WARFARIN SODIUM CLATHRATE EQUIVALENT TO WARFARIN SODIUM 1,0 mg | 1 mg | 41012041/8.2/0120 | Cancelled | S4 | None |
| Cipla-warfarin 3 MG EACH TABLET CONTAINS WARFARIN SODIUM CLATHRATE EQUIVALENT TO WARFARIN SODIUM 3,0 mg | 3 mg | 41012141/8.2/0121 | Cancelled | S4 | None |
| Zywar 1 EACH TABLET CONTAINS WARFARIN SODIUM 1,0 mg | 1 | 41028241/8.2/0282 | Cancelled | S4 | None |
| Zywar 2,5 EACH TABLET CONTAINS WARFARIN SODIUM 2,5 mg | 2,5 | 41028341/8.2/0283 | Cancelled | S4 | None |
| Zywar 5 EACH TABLET CONTAINS WARFARIN SODIUM 5,0 mg | 5 | 41028441/8.2/0284 | Cancelled | S4 | None |
| Warfarin 3 MG austell EACH TABLET CONTAINS: WARFARIN SODIUM 3,0 mg | 3 mg | 49105549/8.2/1055 | Registered | S4 | None |
| Warfarin 5 MG austell EACH TABLET CONTAINS: WARFARIN SODIUM 5,0 mg | 5 mg | 49105649/8.2/1056 | Registered | S4 | None |
| Warfarin 1 MG apex EACH TABLET CONTAINS: WARFARIN SODIUM 1,0 mg | 1 mg | 49105749/8.2/1057 | Registered | S4 | None |
| Warfarin 3 MG apex EACH TABLET CONTAINS: WARFARIN SODIUM 3,0 mg | 3 mg | 49105849/8.2/1058 | Registered | S4 | None |
| Warfarin 5 MG apex EACH TABLET CONTAINS: WARFARIN SODIUM 5,0 mg | 5 mg | 49105949/8.2/1059 | Registered | S4 | None |
| Warfarin 1 MG camox EACH TABLET CONTAINS: WARFARIN SODIUM 1,0 mg | 1 mg | 49106049/8.2/1060 | Registered | S4 | None |
| Warfarin 3 MG camox EACH TABLET CONTAINS: WARFARIN SODIUM 3,0 mg | 3 mg | 49106149/8.2/1061 | Registered | S4 | None |
| Warfarin 5 MG camox EACH TABLET CONTAINS: WARFARIN SODIUM 5,0 mg | 5 mg | 49106249/8.2/1062 | Registered | S4 | None |
| Warfarin 5 biotech EACH TABLET CONTAINS WARFARIN SODIUM 5,0 mg | 5 mgTablet | 56065856/8.2/0658Approved 26 September 2023 | Registered | S4 | PIPIL |
| Heamawarin EACH TABLET CONTAINS WARFARIN SODIUM 5,0 mg | 5 mgTablet | 560659.65856/8.2/0659.658Approved 26 September 2023 | Registered | S4 | PIPIL |
| Cowarin 5 MG Each Tablet contains: Warfarin Sodium 5,0 mg | 5 mg | 57042657/8.2/0426 | Registered | S4 | None |
| Cipla-warfarin 5 MG EACH TABLET CONTAINS WARFARIN SODIUM EQUIVALENT TO WARFARIN 5,0 mg | 5 mg | A380422A38/8.2/0422 | Registered | S4 | None |
| Aspen warfarin 5 MG EACH TABLET CONTAINS WARFARIN SODIUM CLATHRATE EQUIVALENT TO WARFARIN SODIUM 5,0 mg | 5 mg | H0742H/8.2/0742 | Registered | S4 | None |
| Coumadin 5 TABLET WARFARIN SODIUM A 5 MG | 5 | H0753 | Old Medicine | S4 | None |
| Coumadin EACH VIAL CONTAINS WARFARIN SODIUM A 50 MG | Not listed | H0757 | Cancelled | S4 | None |
Regulatory status
Where S4 sits on the scale
Prescription-only medicine.
Schedule 4 covers most ordinary prescription medicines. You need a prescription from an authorised prescriber, such as a doctor or dentist, and a pharmacist dispenses it. Its price, name, pack size and strength can still be told to the public, as long as nothing links it to what it treats.
Schedule S4, matched to the Consolidated Schedules by ingredient, confidence high.
Who may supply: A pharmacist dispensing against a written or verbal prescription from an authorised prescriber; a veterinarian, who may also prescribe, compound or dispense it directly; a medical practitioner or dentist, who may prescribe it and may compound or dispense it directly only if licensed under section 22C(1)(a); manufacturers and wholesalers may supply people who may lawfully possess it; and, for animal treatment, a person practising a para-veterinary profession, on a veterinarian's written or verbal instruction.
Consolidated Schedules listings for Warfarin sodium
S4: Warfarin
Consolidated Schedules 06 July 2026, line 8402
Pharmacological class: Anticoagulants. (class 8.2)
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
SAHPRA documents
Schedule Verification
Warfarin 5 biotech, Biotech Laboratories (Pty) Ltd is scheduled S4 in its official SAHPRA documents, read with 90% confidence.
These documents are provided by SAHPRA for informational purposes. Always consult with a healthcare professional for medical advice.